ClinicalTrials.Veeva

Menu

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children (NoseFlu-Kids)

University Hospitals (UH) logo

University Hospitals (UH)

Status

Enrolling

Conditions

Influenza Infection

Study type

Observational

Funder types

Other

Identifiers

NCT06998264
2024-01409

Details and patient eligibility

About

The NoseFlu-Kids project aims at characterizing the immune response in the upper respiratory tract in children aged 2 to 5 with a laboratory-confirmed influenza infection. The immune response during the acute phase of the infection and after recovery will be compared to that of control children with no infection or vaccinated with the inactivated flu vaccine by the nasal route (recruited as part of a mirror study in Oxford).

The primary objective of this observational study is to quantify the inflammatory response in the nasal cavity and to correlate it with viral load and with clinical parameters. The study also aims to compare the inflammatory response measured in the nose to that measured in the blood.

Participants will have two study visits including a blood draw, several nasal samplings (nasal lining fluid and nasal cells) and a saliva sampling, one within 72 hours of their hospital admission and another one month later. Nasal lining fluid and saliva will be obtained every two or three days until symptoms disappear. During those visits, questions regarding symptoms will be asked.

Enrollment

40 estimated patients

Sex

All

Ages

2 to 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 2-5 years
  • Presenting clinical signs of an influenza-like illness
  • Having a concomitant positive laboratory test for influenza.

Exclusion criteria

  • Immunosuppression
  • Intubation or under invasive mechanical ventilation
  • Co-infection with RSV or SARS-CoV-2

Trial design

40 participants in 1 patient group

Flu kids
Description:
Patients aged 2-5 years old hospitalized with flu-like symptoms and a laboratory-confirmed influenza infection

Trial contacts and locations

1

Loading...

Central trial contact

Jennifer Villers, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems